Skip to main content

Table 2 Clinical characteristics of glucose, thyroid hormone, thyroid antibodies, and oxidative stress parameters in control and Hashimoto′s thyroiditis

From: Receptor of advanced glycation end product (RAGE) polymorphism and oxidative status in Hashimoto’s thyroiditis in Egyptian female patients: case control study

Parameter

Cases group N = 80

Control group N = 80

P value

Glucose(mg/dl)

96.1 ± 12.1

96.5 ± 29.3

0.93(NS)

FT3(Pg/ml)

3.37 ± 1.12

3.44 ± 0.33

0.7 (NS)

FT4(Pg/ml)

10.33 ± 1.66

11.11 ± 2.03

0.063 (NS)

TSH

17.76 ± 11.03

1.2 ± 1.14

 < 0.001*(S)

anti-Tg-AB (IU/L)

380.93 ± 173.02

2.7 ± 1.4

 < 0.001*(S)

MDA (nmol/ml)

9.1 ± 1.22

1.33 ± 0.06

 < 0.001*(S)

TAC (nmol/L)

1.2 ± 0.21

2.6 ± 0.9

 < 0.001*(S)

  1. fT3 (free triiodothyronine), fT4 (free thyroxine), TSH (thyroid-stimulating hormone, Tg (anti-thyroglobulin antibody), MDA (malondialdehyde), TAC total antioxidant capacity
  2. The data is represented as mean ± SD
  3. (NS)non-significant, (S)* Significant values